People on the Move
ReNeuron
UK stem cell company ReNeuron has appointed Olav Hellebø, as CEO.
Hellebø has significant experience in clinical development, out-licensing, and commercialisation of new therapies from his time as CEO of Clavis Pharma ASA, a Norwegian oncology biotech, and from heading up UCB Pharma’s global biologics franchise and the UK commercial operations of Novartis.
Michael Hunt, the outgoing CEO, will remain on ReNeuron’s board as Chief Financial Officer.
Earlier this year, ReNeuron relocated its headquarters and operations from Surrey, England to Cardiff, Wales, after leasing an R&D and manufacturing facility from the Welsh government.
